Effect of incremental exercise on airway and systemic inflammation in patients with COPD

Journal of Applied Physiology

Volumn 112, Issue 12, 2012, Pages 2049-2056

  Davidson, Warren J ^a   Verity, Wendy S ^a   Traves, Suzanne L ^a   Leigh, Richard ^a   Ford, Gordon T ^a   Eves, Neil D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anti inflammatory; Chronic obstructive lung disease; Immune function; Physical activity

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CCL5 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; RANTES;

AGED; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EOSINOPHIL; EXERCISE; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; SPUTUM;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL5; EOSINOPHILS; EXERCISE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKINS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM; SPUTUM;

EID: 84862569311     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01615.2011     Document Type: Article

References (66)

1. American Thoracic Society/American College of Chest Physicians. Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167:211-277, 2003.
2. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, Dales RE. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:349-355, 2001. (Pubitemid 32158511)
3. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 343:269-280, 2000. (Pubitemid 30490396)
4. Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, Barnes PJ. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 123:1240-1247, 2003. (Pubitemid 36444384)
5. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 55:114-120, 2000. (Pubitemid 30245950)
6. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377-381, 1982. (Pubitemid 13215050)
7. Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 60:193-198, 2005. (Pubitemid 40380276)
8. Bruunsgaard H, Galbo H, Halkjaer-Kristensen J, Johansen TL, MacLean DA, Pedersen BK. Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. J Physiol 499:833-841, 1997. (Pubitemid 27153602)
9. Burrows B, Kasik JE, Niden AH, Barclay WR. Clinical usefulness of the single-breath pulmonucy diffusing capacity test. Am Rev Respir Dis 84:789-806, 1961.
10. Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopath Respir 18:419-425, 1982. (Pubitemid 12117075)
11. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-alpha production by peripheral blood monocytes of weightlosing COPD patients. Am J Respir Crit Care Med 153:633-637, 1996.
12. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 158:1277-1285, 1998. (Pubitemid 28489033)
13. Di Stefano A, Caramori G, Gnemmi I, Contoli M, Bristot L, Capelli A, Ricciardolo FL, Magno F, D'Anna SE, Zanini A, Carbone M, Sabatini F, Usai C, Brun P, Chung KF, Barnes PJ, Papi A, Adcock IM, Balbi B. Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax 64:968-975, 2009.
14. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37:247-248, 1974.
15. Dolmage TE, Goldstein RS. Repeatability of inspiratory capacity during incremental exercise in patients with severe COPD. Chest 121:708-714, 2002. (Pubitemid 34251432)
16. Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, Pizzichini MM, Pizzichini E, Ronchi C, Van Overvel F, Djukanovic R. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl 37:19s-23s, 2002. (Pubitemid 35024263)
17. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 370:797-799, 2007. (Pubitemid 47320803)
18. Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 25:640-646, 2005. (Pubitemid 40528756)
19. Gauvreau GM, Ronnen GM, Watson RM, O'Byrne PM. Exerciseinduced bronchoconstriction does not cause eosinophilic airway inflammation or airway hyperresponsiveness in subjects with asthma. Am J Respir Crit Care Med 162:1302-1307, 2000.
20. Gauvreau GM, Watson RM, O'Byrne PM. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med 160:640-647, 1999. (Pubitemid 29380685)
21. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, Kheradmand F. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 1:e8, 2004.
22. Hacievliyagil SS, Gunen H, Mutlu LC, Karabulut AB, Temel I. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med 100:846-854, 2006.
23. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364:709-721, 2004. (Pubitemid 39140629)
24. Huhn RD, Radwanski E, O'Connell SM, Sturgill MG, Clarke L, Cody RP, Affrime MB, Cutler DL. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 87:699-705, 1996. (Pubitemid 26031078)
25. Johansen LB, Videbaek R, Hammerum M, Norsk P. Underestimation of plasma volume changes in humans by hematocrit/hemoglobin method. Am J Physiol Regul Integr Comp Physiol 274:R126-R130, 1998.
26. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176:587-592, 1992.
27. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 127:725-734, 1983. (Pubitemid 13101554)
28. Kojima H, Shinohara N, Hanaoka S, Someya-Shirota Y, Takagaki Y, Ohno H, Saito T, Katayama T, Yagita H, Okumura K. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357-364, 1994.
29. Lacoste JY, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 92:537-548, 1993. (Pubitemid 23317079)
30. Laub M, Hvid-Jacobsen K, Hovind P, Kanstrup IL, Christensen NJ, Nielsen SL. Spleen emptying and venous hematocrit in humans during exercise. J Appl Physiol 74:1024-1026, 1993. (Pubitemid 23118548)
31. Leigh R, Pizzichini MM, Morris MM, Maltais F, Hargreave FE, Pizzichini E. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J 27:964-971, 2006. (Pubitemid 44911110)
32. Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J 12:871-880, 1998. (Pubitemid 28294677)
33. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720-735, 2005. (Pubitemid 41448672)
34. Maeno T, Houghton AM, Quintero PA, Grumelli S, Owen CA, Shapiro SD. CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol 178:8090-8096, 2007. (Pubitemid 46898081)
35. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 17:946-953, 2001. (Pubitemid 32600344)
36. Makris D, Lazarou S, Alexandrakis M, Kourelis TV, Tzanakis N, Kyriakou D, Gourgoulianis KI. Tc2 response at the onset of COPD exacerbations. Chest 134:483-488, 2008.
37. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442, 2006.
38. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 62:411-415, 2007. (Pubitemid 46698390)
39. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 26:319-338, 2005. (Pubitemid 41079078)
40. Nightingale JA, Rogers DF, Barnes PJ. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax 53:87-90, 1998. (Pubitemid 28212131)
41. Northoff H, Weinstock C, Berg A. The cytokine response to strenuous exercise. Int J Sports Med 15, Suppl 3:S167-S171, 1994. (Pubitemid 24355917)
42. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro-and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515:287-291, 1999. (Pubitemid 29092641)
43. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173:1114-1121, 2006. (Pubitemid 43726892)
44. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80:1055-1081, 2000. (Pubitemid 30452011)
45. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 98:1154-1162, 2005. (Pubitemid 40396484)
46. Petersen AM, Pedersen BK. The role of IL-6 in mediating the antiinflammatory effects of exercise. J Physiol Pharmacol 57, Suppl 10:43-51, 2006. (Pubitemid 46548766)
47. Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 9:1174-1180, 1996. (Pubitemid 26231731)
48. Pizzichini E, Pizzichini MM, Gibson P, Parameswaran K, Gleich GJ, Berman L, Dolovich J, Hargreave FE. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 158:1511-1517, 1998.
49. Rabinovich RA, Figueras M, Ardite E, Carbo N, Troosters T, Filella X, Barbera JA, Fernandez-Checa JC, Argiles JM, Roca J. Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J 21:789-794, 2003. (Pubitemid 36592286)
50. Saetta M, Di Stefano A, Maestrelli P, Turato G, Mapp CE, Pieno M, Zanguochi G, Del Prete G, Fabbri LM. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy 26:766-774, 1996. (Pubitemid 26266421)
51. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 3:165-183, 1991.
52. Seggev JS, Thornton WH Jr, Edes TE. Serum leukotriene B4 levels in patients with obstructive pulmonary disease. Chest 99:289-291, 1991.
53. Senay LC Jr, Rogers G, Jooste P. Changes in blood plasma during progressive treadmill and cycle exercise. J Appl Physiol 49:59-65, 1980. (Pubitemid 10043020)
54. Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol Appendix 3: Appendix 3B, 2001.
55. Stubbing DG, Pengelly LD, Morse JL, Jones NL. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 49:511-515, 1980. (Pubitemid 10009085)
56. Suzuki K, Yamada M, Kurakake S, Okamura N, Yamaya K, Liu Q, Kudoh S, Kowatari K, Nakaji S, Sugawara K. Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. Eur J Appl Physiol 81:281-287, 2000. (Pubitemid 30189950)
57. Swanson BJ, Murakami M, Mitchell TC, Kappler J, Marrack P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 17:605-615, 2002. (Pubitemid 35351506)
58. Tzanakis N, Chrysofakis G, Tsoumakidou M, Kyriakou D, Tsiligianni J, Bouros D, Siafakas NM. Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 98:57-65, 2004. (Pubitemid 38100756)
59. van der Vaart H, Postma DS, Timens W, Kauffman HF, Hylkema MN, Ten Hacken NH. Repeated sputum inductions induce a transient neutrophilic and eosinophilic response. Chest 130:1157-1164, 2006. (Pubitemid 44583748)
60. van Helvoort HA, Heijdra YF, de Boer RC, Swinkels A, Thijs HM, Dekhuijzen PN. Six-minute walking-induced systemic inflammation and oxidative stress in muscle-wasted COPD patients. Chest 131:439-445, 2007. (Pubitemid 46280404)
61. Van Helvoort HA, Heijdra YF, Thijs HM, Vina J, Wanten GJ, Dekhuijzen PN. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc 38:1543-1552, 2006. (Pubitemid 44373772)
62. van Helvoort HA, van de Pol MH, Heijdra YF, Dekhuijzen PN. Systemic inflammatory response to exhaustive exercise in patients with chronic obstructive pulmonary disease. Respir Med 99:1555-1567, 2005. (Pubitemid 41683936)
63. Walzer T, Marcais A, Saltel F, Bella C, Jurdic P, Marvel J. Cutting edge: immediate RANTES secretion by resting memory CD8 T cells following antigenic stimulation. J Immunol 170:1615-1619, 2003. (Pubitemid 36197372)
64. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. Eur Respir J 26:511-522, 2005. (Pubitemid 41264217)
65. Yamamoto C, Yoneda T, Yoshikawa M, Fu A, Tokuyama T, Tsukaguchi K, Narita N. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 112:505-510, 1997. (Pubitemid 27349446)
66. Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156:55-59, 1997. (Pubitemid 27293167)